Health Care Falls as Traders Flee Defensive Areas -- Health Care Roundup

Shares of health-care companies fell as traders rotated out of defensive areas into rate-sensitive financial stocks.

AstraZeneca said its Fasenra asthma treatment has received European Union approval following late stage trials.

The results of a drug trial jointly operated by Merck and Incyte, due to be released by midyear, will help shape the future of drug makers' immunotherapy products, a promising line of cancer treatments.

Rob Curran,

(END) Dow Jones Newswires

January 10, 2018 16:57 ET (21:57 GMT)